StoneX Group
MAIA icon

StoneX Group’s MAIA Biotechnology MAIA Stock Holding History

StoneX Group’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$77.7K Buy
+60,151
New +$80.9K ﹤0.01% 1539
2026
Q1 		– Sell
-10,249
Closed -$15.7K – 1112
2025
Q4 		$15.7K Buy
+10,249
New +$13.4K ﹤0.01% 982

Other funds holding MAIA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
PVG Asset Management
PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return
Lazari Capital Management
Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Centerpoint Advisory Group
Centerpoint Advisory Group Overland Park, Kansas $161M AUM 19.32% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Daytona Street Capital
Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

StoneX Group's MAIA Position: Q3 2026 in Review

StoneX Group opened a new position in MAIA Biotechnology (MAIA) in Q3 2026: 60,151 shares worth $77.7K. The stake represents ﹤0.01% of the portfolio and ranks #1539 among its holdings. This is a return to the name: StoneX Group previously reported a position in MAIA as recently as Q4 2025.

StoneX Group first reported a position in MAIA in Q4 2025 and has held it in 2 quarters since. 11 funds tracked by Wall St. Rank hold MAIA as of Q3 2026.

  • StoneX Group held 60,151 shares of MAIA Biotechnology worth $77.7K as of Q3 2026.
  • MAIA Biotechnology was a new StoneX Group position in Q3 2026.
  • MAIA Biotechnology made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1539 holding.
  • StoneX Group first reported a position in MAIA Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • 11 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.